Lenvima 20 MG daily dose 60S
Ended Awarded
- Contract number
- SPE2DX25F6ADT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $11,354
Award facts
- Contract value 100% obligated
- $11,353.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. for LENVIMA 20 mg daily dose (60-count supply) valued at $11,353.77 on August 21, 2025, with completion expected by September 12, 2025. This firm fixed-price delivery order was awarded without set-aside designation to the Park Ridge, Illinois-based woman-owned small business pharmaceutical wholesaler. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the issuance of delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through its robust portfolio of contracts with the DLA covering branded and generic prescription medications, biologics, and medical consumables. LENVIMA is an oncology treatment used in cancer therapy, consistent with the company's track record of delivering specialized pharmaceutical products such as Tecentriq, Xtandi, and other specialty medications to Department of Defense healthcare sites. The company's status as a registered woman-owned small business, combined with its long-standing relationship with federal agencies since 2001 registration in SAM.gov, positions it competitively in federal pharmaceutical procurement markets.
Quick answers
Who was awarded contract SPE2DX25F6ADT?
SPE2DX25F6ADT was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 21, 2025.
How much is contract SPE2DX25F6ADT worth?
The government has obligated $11,354 on SPE2DX25F6ADT.
Is contract SPE2DX25F6ADT an order under another contract?
Yes. SPE2DX25F6ADT is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ADT competed?
The extent of competition for SPE2DX25F6ADT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award